16-[2-(1-phenylbenzimidazol-2-yl)phenyl]-2,8,16-triazatetracyclo[7.7.0.02,7.010,15]hexadeca-1(9),3,5,7,10,12,14-heptaene;16-[2-(2-phenylbenzimidazol-1-yl)phenyl]-2,8,16-triazatetracyclo[7.7.0.02,7.010,15]hexadeca-1(9),3,5,7,10,12,14-heptaene;16-[4-(4-phenylphenyl)quinazolin-2-yl]-2,8,16-triazatetracyclo[7.7.0.02,7.010,15]hexadeca-1(9),3,5,7,10,12,14-heptaene;16-[4-(4-phenylquinazolin-2-yl)phenyl]-2,8,16-triazatetracyclo[7.7.0.02,7.010,15]hexadeca-1(9),3,5,7,10,12,14-heptaene;16-(4-phenylquinazolin-2-yl)-2,8,16-triazatetracyclo[7.7.0.02,7.010,15]hexadeca-1(9),3,5,7,10,12,14-heptaene

C157H101N25 — CID 158475803

IUPAC16-[2-(1-phenylbenzimidazol-2-yl)phenyl]-2,8,16-triazatetracyclo[7.7.0.02,7.010,15]hexadeca-1(9),3,5,7,10,12,14-heptaene;16-[2-(2-phenylbenzimidazol-1-yl)phenyl]-2,8,16-triazatetracyclo[7.7.0.02,7.010,15]hexadeca-1(9),3,5,7,10,12,14-heptaene;16-[4-(4-phenylphenyl)quinazolin-2-yl]-2,8,16-triazatetracyclo[7.7.0.02,7.010,15]hexadeca-1(9),3,5,7,10,12,14-heptaene;16-[4-(4-phenylquinazolin-2-yl)phenyl]-2,8,16-triazatetracyclo[7.7.0.02,7.010,15]hexadeca-1(9),3,5,7,10,12,14-heptaene;16-(4-phenylquinazolin-2-yl)-2,8,16-triazatetracyclo[7.7.0.02,7.010,15]hexadeca-1(9),3,5,7,10,12,14-heptaene
SMILESc1ccc(-c2ccc(-c3nc(-n4c5ccccc5c5nc6ccccn6c54)nc4ccccc34)cc2)cc1.c1ccc(-c2nc(-c3ccc(-n4c5ccccc5c5nc6ccccn6c54)cc3)nc3ccccc23)cc1.c1ccc(-c2nc(-n3c4ccccc4c4nc5ccccn5c43)nc3ccccc23)cc1.c1ccc(-c2nc3ccccc3n2-c2ccccc2-n2c3ccccc3c3nc4ccccn4c32)cc1.c1ccc(-n2c(-c3ccccc3-n3c4ccccc4c4nc5ccccn5c43)nc3ccccc32)cc1
InChIInChI=1S/2C33H21N5.2C32H21N5.C27H17N5/c1-2-10-22(11-3-1)30-25-12-4-6-14-27(25)34-32(36-30)23-17-19-24(20-18-23)38-28-15-7-5-13-26(28)31-33(38)37-21-9-8-16-29(37)35-31;1-2-10-22(11-3-1)23-17-19-24(20-18-23)30-25-12-4-6-14-27(25)34-33(36-30)38-28-15-7-5-13-26(28)31-32(38)37-21-9-8-16-29(37)35-31;1-2-12-22(13-3-1)36-28-19-9-6-16-25(28)33-31(36)24-15-5-8-18-27(24)37-26-17-7-4-14-23(26)30-32(37)35-21-11-10-20-29(35)34-30;1-2-12-22(13-3-1)31-33-24-15-5-7-17-26(24)36(31)27-18-8-9-19-28(27)37-25-16-6-4-14-23(25)30-32(37)35-21-11-10-20-29(35)34-30;1-2-10-18(11-3-1)24-19-12-4-6-14-21(19)28-27(30-24)32-22-15-7-5-13-20(22)25-26(32)31-17-9-8-16-23(31)29-25/h2*1-21H;2*1-21H;1-17H
InChIKeyHGXLFZWWYMAVEQ-UHFFFAOYSA-N
MW2337.71 g/mol
LogP36.33
Rot. Bonds14

About 16-[2-(1-phenylbenzimidazol-2-yl)phenyl]-2,8,16-triazatetracyclo[7.7.0.02,7.010,15]hexadeca-1(9),3,5,7,10,12,14-heptaene;16-[2-(2-phenylbenzimidazol-1-yl)phenyl]-2,8,16-triazatetracyclo[7.7.0.02,7.010,15]hexadeca-1(9),3,5,7,10,12,14-heptaene;16-[4-(4-phenylphenyl)quinazolin-2-yl]-2,8,16-triazatetracyclo[7.7.0.02,7.010,15]hexadeca-1(9),3,5,7,10,12,14-heptaene;16-[4-(4-phenylquinazolin-2-yl)phenyl]-2,8,16-triazatetracyclo[7.7.0.02,7.010,15]hexadeca-1(9),3,5,7,10,12,14-heptaene;16-(4-phenylquinazolin-2-yl)-2,8,16-triazatetracyclo[7.7.0.02,7.010,15]hexadeca-1(9),3,5,7,10,12,14-heptaene

16-[2-(1-phenylbenzimidazol-2-yl)phenyl]-2,8,16-triazatetracyclo[7.7.0.02,7.010,15]hexadeca-1(9),3,5,7,10,12,14-heptaene;16-[2-(2-phenylbenzimidazol-1-yl)phenyl]-2,8,16-triazatetracyclo[7.7.0.02,7.010,15]hexadeca-1(9),3,5,7,10,12,14-heptaene;16-[4-(4-phenylphenyl)quinazolin-2-yl]-2,8,16-triazatetracyclo[7.7.0.02,7.010,15]hexadeca-1(9),3,5,7,10,12,14-heptaene;16-[4-(4-phenylquinazolin-2-yl)phenyl]-2,8,16-triazatetracyclo[7.7.0.02,7.010,15]hexadeca-1(9),3,5,7,10,12,14-heptaene;16-(4-phenylquinazolin-2-yl)-2,8,16-triazatetracyclo[7.7.0.02,7.010,15]hexadeca-1(9),3,5,7,10,12,14-heptaene (PubChem CID 158475803) has the molecular formula C157H101N25 and a molecular weight of 2337.71 g/mol. Its IUPAC name is 16-[2-(1-phenylbenzimidazol-2-yl)phenyl]-2,8,16-triazatetracyclo[7.7.0.02,7.010,15]hexadeca-1(9),3,5,7,10,12,14-heptaene;16-[2-(2-phenylbenzimidazol-1-yl)phenyl]-2,8,16-triazatetracyclo[7.7.0.02,7.010,15]hexadeca-1(9),3,5,7,10,12,14-heptaene;16-[4-(4-phenylphenyl)quinazolin-2-yl]-2,8,16-triazatetracyclo[7.7.0.02,7.010,15]hexadeca-1(9),3,5,7,10,12,14-heptaene;16-[4-(4-phenylquinazolin-2-yl)phenyl]-2,8,16-triazatetracyclo[7.7.0.02,7.010,15]hexadeca-1(9),3,5,7,10,12,14-heptaene;16-(4-phenylquinazolin-2-yl)-2,8,16-triazatetracyclo[7.7.0.02,7.010,15]hexadeca-1(9),3,5,7,10,12,14-heptaene.

Molecular Properties

Compound Name16-[2-(1-phenylbenzimidazol-2-yl)phenyl]-2,8,16-triazatetracyclo[7.7.0.02,7.010,15]hexadeca-1(9),3,5,7,10,12,14-heptaene;16-[2-(2-phenylbenzimidazol-1-yl)phenyl]-2,8,16-triazatetracyclo[7.7.0.02,7.010,15]hexadeca-1(9),3,5,7,10,12,14-heptaene;16-[4-(4-phenylphenyl)quinazolin-2-yl]-2,8,16-triazatetracyclo[7.7.0.02,7.010,15]hexadeca-1(9),3,5,7,10,12,14-heptaene;16-[4-(4-phenylquinazolin-2-yl)phenyl]-2,8,16-triazatetracyclo[7.7.0.02,7.010,15]hexadeca-1(9),3,5,7,10,12,14-heptaene;16-(4-phenylquinazolin-2-yl)-2,8,16-triazatetracyclo[7.7.0.02,7.010,15]hexadeca-1(9),3,5,7,10,12,14-heptaene
PubChem CID158475803
Molecular FormulaC157H101N25
Molecular Weight2337.71 g/mol
Exact Mass2335.87
IUPAC Name16-[2-(1-phenylbenzimidazol-2-yl)phenyl]-2,8,16-triazatetracyclo[7.7.0.02,7.010,15]hexadeca-1(9),3,5,7,10,12,14-heptaene;16-[2-(2-phenylbenzimidazol-1-yl)phenyl]-2,8,16-triazatetracyclo[7.7.0.02,7.010,15]hexadeca-1(9),3,5,7,10,12,14-heptaene;16-[4-(4-phenylphenyl)quinazolin-2-yl]-2,8,16-triazatetracyclo[7.7.0.02,7.010,15]hexadeca-1(9),3,5,7,10,12,14-heptaene;16-[4-(4-phenylquinazolin-2-yl)phenyl]-2,8,16-triazatetracyclo[7.7.0.02,7.010,15]hexadeca-1(9),3,5,7,10,12,14-heptaene;16-(4-phenylquinazolin-2-yl)-2,8,16-triazatetracyclo[7.7.0.02,7.010,15]hexadeca-1(9),3,5,7,10,12,14-heptaene
SMILESc1ccc(-c2ccc(-c3nc(-n4c5ccccc5c5nc6ccccn6c54)nc4ccccc34)cc2)cc1.c1ccc(-c2nc(-c3ccc(-n4c5ccccc5c5nc6ccccn6c54)cc3)nc3ccccc23)cc1.c1ccc(-c2nc(-n3c4ccccc4c4nc5ccccn5c43)nc3ccccc23)cc1.c1ccc(-c2nc3ccccc3n2-c2ccccc2-n2c3ccccc3c3nc4ccccn4c32)cc1.c1ccc(-n2c(-c3ccccc3-n3c4ccccc4c4nc5ccccn5c43)nc3ccccc32)cc1
InChIInChI=1S/2C33H21N5.2C32H21N5.C27H17N5/c1-2-10-22(11-3-1)30-25-12-4-6-14-27(25)34-32(36-30)23-17-19-24(20-18-23)38-28-15-7-5-13-26(28)31-33(38)37-21-9-8-16-29(37)35-31;1-2-10-22(11-3-1)23-17-19-24(20-18-23)30-25-12-4-6-14-27(25)34-33(36-30)38-28-15-7-5-13-26(28)31-32(38)37-21-9-8-16-29(37)35-31;1-2-12-22(13-3-1)36-28-19-9-6-16-25(28)33-31(36)24-15-5-8-18-27(24)37-26-17-7-4-14-23(26)30-32(37)35-21-11-10-20-29(35)34-30;1-2-12-22(13-3-1)31-33-24-15-5-7-17-26(24)36(31)27-18-8-9-19-28(27)37-25-16-6-4-14-23(25)30-32(37)35-21-11-10-20-29(35)34-30;1-2-10-18(11-3-1)24-19-12-4-6-14-21(19)28-27(30-24)32-22-15-7-5-13-20(22)25-26(32)31-17-9-8-16-23(31)29-25/h2*1-21H;2*1-21H;1-17H
InChIKeyHGXLFZWWYMAVEQ-UHFFFAOYSA-N
XLogP36.33
TPSA224.13 Ų
H-Bond Donors
H-Bond Acceptors25
Rotatable Bonds14
Heavy Atoms182
Complexity—

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002337.71
LogP ≤ 536.33
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 1025

Analyze 16-[2-(1-phenylbenzimidazol-2-yl)phenyl]-2,8,16-triazatetracyclo[7.7.0.02,7.010,15]hexadeca-1(9),3,5,7,10,12,14-heptaene;16-[2-(2-phenylbenzimidazol-1-yl)phenyl]-2,8,16-triazatetracyclo[7.7.0.02,7.010,15]hexadeca-1(9),3,5,7,10,12,14-heptaene;16-[4-(4-phenylphenyl)quinazolin-2-yl]-2,8,16-triazatetracyclo[7.7.0.02,7.010,15]hexadeca-1(9),3,5,7,10,12,14-heptaene;16-[4-(4-phenylquinazolin-2-yl)phenyl]-2,8,16-triazatetracyclo[7.7.0.02,7.010,15]hexadeca-1(9),3,5,7,10,12,14-heptaene;16-(4-phenylquinazolin-2-yl)-2,8,16-triazatetracyclo[7.7.0.02,7.010,15]hexadeca-1(9),3,5,7,10,12,14-heptaene with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

16-[4-(2-phenylphenyl)phenyl]-2,8,16-triazatetracyclo[7.7.0.02,7.010,15]hexadeca-1(9),3,5,7,10,12,14-heptaene
CID 118458480
1-phenyl-2-[4-[3-phenyl-5-[4-(2-phenylimidazo[1,2-a]pyridin-3-yl)phenyl]phenyl]phenyl]benzimidazole
CID 155306860
2-phenyl-1-[4-[3-phenyl-5-[4-(3-phenylimidazo[1,2-a]pyridin-2-yl)phenyl]phenyl]phenyl]benzimidazole
CID 155306933
CID 159784905
CID 159784905
9-[3-[4-(1-phenylbenzimidazol-2-yl)phenyl]phenyl]-8,11,17-triazatetracyclo[8.7.0.02,7.011,16]heptadeca-1(10),2,4,6,8,12,14,16-octaene
CID 130393336
1-phenyl-2-[4-[4-(4,5,6-triphenylpyrimidin-2-yl)phenyl]phenyl]benzimidazole
CID 155140715
2,3-bis[3-(4-phenylquinazolin-2-yl)phenyl]quinazolin-4-one;2-phenyl-3-[4-(2-phenylbenzimidazol-1-yl)phenyl]quinazolin-4-one;3-phenyl-2-[4-(2-phenylbenzimidazol-1-yl)phenyl]quinazolin-4-one
CID 159155859
2-[3-naphthalen-1-yl-5-[3-(2-phenylimidazo[1,2-a]pyridin-3-yl)phenyl]phenyl]-1-phenylbenzimidazole
CID 155306971
2-phenyl-1-[3-[3-phenyl-5-[4-(2-phenylimidazo[1,2-a]pyridin-3-yl)phenyl]phenyl]phenyl]benzimidazole
CID 164781227
9-[4-[4-[4-[4-[4-(1-phenylbenzimidazol-2-yl)phenyl]phenyl]phenyl]phenyl]phenyl]carbazole
CID 58470934
1-[4-[4,6-bis[4-(2-phenylbenzimidazol-1-yl)phenyl]-1,3,5-triazin-2-yl]phenyl]-2-phenylbenzimidazole
CID 152919581
1-phenyl-2-[3-[3-phenyl-5-[3-(2-phenylimidazo[1,2-a]pyridin-3-yl)phenyl]phenyl]phenyl]benzimidazole
CID 164781287

Frequently Asked Questions

What is the IUPAC name of 16-[2-(1-phenylbenzimidazol-2-yl)phenyl]-2,8,16-triazatetracyclo[7.7.0.02,7.010,15]hexadeca-1(9),3,5,7,10,12,14-heptaene;16-[2-(2-phenylbenzimidazol-1-yl)phenyl]-2,8,16-triazatetracyclo[7.7.0.02,7.010,15]hexadeca-1(9),3,5,7,10,12,14-heptaene;16-[4-(4-phenylphenyl)quinazolin-2-yl]-2,8,16-triazatetracyclo[7.7.0.02,7.010,15]hexadeca-1(9),3,5,7,10,12,14-heptaene;16-[4-(4-phenylquinazolin-2-yl)phenyl]-2,8,16-triazatetracyclo[7.7.0.02,7.010,15]hexadeca-1(9),3,5,7,10,12,14-heptaene;16-(4-phenylquinazolin-2-yl)-2,8,16-triazatetracyclo[7.7.0.02,7.010,15]hexadeca-1(9),3,5,7,10,12,14-heptaene?
The IUPAC name of 16-[2-(1-phenylbenzimidazol-2-yl)phenyl]-2,8,16-triazatetracyclo[7.7.0.02,7.010,15]hexadeca-1(9),3,5,7,10,12,14-heptaene;16-[2-(2-phenylbenzimidazol-1-yl)phenyl]-2,8,16-triazatetracyclo[7.7.0.02,7.010,15]hexadeca-1(9),3,5,7,10,12,14-heptaene;16-[4-(4-phenylphenyl)quinazolin-2-yl]-2,8,16-triazatetracyclo[7.7.0.02,7.010,15]hexadeca-1(9),3,5,7,10,12,14-heptaene;16-[4-(4-phenylquinazolin-2-yl)phenyl]-2,8,16-triazatetracyclo[7.7.0.02,7.010,15]hexadeca-1(9),3,5,7,10,12,14-heptaene;16-(4-phenylquinazolin-2-yl)-2,8,16-triazatetracyclo[7.7.0.02,7.010,15]hexadeca-1(9),3,5,7,10,12,14-heptaene (CID 158475803) is 16-[2-(1-phenylbenzimidazol-2-yl)phenyl]-2,8,16-triazatetracyclo[7.7.0.02,7.010,15]hexadeca-1(9),3,5,7,10,12,14-heptaene;16-[2-(2-phenylbenzimidazol-1-yl)phenyl]-2,8,16-triazatetracyclo[7.7.0.02,7.010,15]hexadeca-1(9),3,5,7,10,12,14-heptaene;16-[4-(4-phenylphenyl)quinazolin-2-yl]-2,8,16-triazatetracyclo[7.7.0.02,7.010,15]hexadeca-1(9),3,5,7,10,12,14-heptaene;16-[4-(4-phenylquinazolin-2-yl)phenyl]-2,8,16-triazatetracyclo[7.7.0.02,7.010,15]hexadeca-1(9),3,5,7,10,12,14-heptaene;16-(4-phenylquinazolin-2-yl)-2,8,16-triazatetracyclo[7.7.0.02,7.010,15]hexadeca-1(9),3,5,7,10,12,14-heptaene.
What is the SMILES notation for 16-[2-(1-phenylbenzimidazol-2-yl)phenyl]-2,8,16-triazatetracyclo[7.7.0.02,7.010,15]hexadeca-1(9),3,5,7,10,12,14-heptaene;16-[2-(2-phenylbenzimidazol-1-yl)phenyl]-2,8,16-triazatetracyclo[7.7.0.02,7.010,15]hexadeca-1(9),3,5,7,10,12,14-heptaene;16-[4-(4-phenylphenyl)quinazolin-2-yl]-2,8,16-triazatetracyclo[7.7.0.02,7.010,15]hexadeca-1(9),3,5,7,10,12,14-heptaene;16-[4-(4-phenylquinazolin-2-yl)phenyl]-2,8,16-triazatetracyclo[7.7.0.02,7.010,15]hexadeca-1(9),3,5,7,10,12,14-heptaene;16-(4-phenylquinazolin-2-yl)-2,8,16-triazatetracyclo[7.7.0.02,7.010,15]hexadeca-1(9),3,5,7,10,12,14-heptaene?
The canonical SMILES for 16-[2-(1-phenylbenzimidazol-2-yl)phenyl]-2,8,16-triazatetracyclo[7.7.0.02,7.010,15]hexadeca-1(9),3,5,7,10,12,14-heptaene;16-[2-(2-phenylbenzimidazol-1-yl)phenyl]-2,8,16-triazatetracyclo[7.7.0.02,7.010,15]hexadeca-1(9),3,5,7,10,12,14-heptaene;16-[4-(4-phenylphenyl)quinazolin-2-yl]-2,8,16-triazatetracyclo[7.7.0.02,7.010,15]hexadeca-1(9),3,5,7,10,12,14-heptaene;16-[4-(4-phenylquinazolin-2-yl)phenyl]-2,8,16-triazatetracyclo[7.7.0.02,7.010,15]hexadeca-1(9),3,5,7,10,12,14-heptaene;16-(4-phenylquinazolin-2-yl)-2,8,16-triazatetracyclo[7.7.0.02,7.010,15]hexadeca-1(9),3,5,7,10,12,14-heptaene is c1ccc(-c2ccc(-c3nc(-n4c5ccccc5c5nc6ccccn6c54)nc4ccccc34)cc2)cc1.c1ccc(-c2nc(-c3ccc(-n4c5ccccc5c5nc6ccccn6c54)cc3)nc3ccccc23)cc1.c1ccc(-c2nc(-n3c4ccccc4c4nc5ccccn5c43)nc3ccccc23)cc1.c1ccc(-c2nc3ccccc3n2-c2ccccc2-n2c3ccccc3c3nc4ccccn4c32)cc1.c1ccc(-n2c(-c3ccccc3-n3c4ccccc4c4nc5ccccn5c43)nc3ccccc32)cc1.
What is the InChIKey of 16-[2-(1-phenylbenzimidazol-2-yl)phenyl]-2,8,16-triazatetracyclo[7.7.0.02,7.010,15]hexadeca-1(9),3,5,7,10,12,14-heptaene;16-[2-(2-phenylbenzimidazol-1-yl)phenyl]-2,8,16-triazatetracyclo[7.7.0.02,7.010,15]hexadeca-1(9),3,5,7,10,12,14-heptaene;16-[4-(4-phenylphenyl)quinazolin-2-yl]-2,8,16-triazatetracyclo[7.7.0.02,7.010,15]hexadeca-1(9),3,5,7,10,12,14-heptaene;16-[4-(4-phenylquinazolin-2-yl)phenyl]-2,8,16-triazatetracyclo[7.7.0.02,7.010,15]hexadeca-1(9),3,5,7,10,12,14-heptaene;16-(4-phenylquinazolin-2-yl)-2,8,16-triazatetracyclo[7.7.0.02,7.010,15]hexadeca-1(9),3,5,7,10,12,14-heptaene?
The InChIKey is HGXLFZWWYMAVEQ-UHFFFAOYSA-N. The full InChI is InChI=1S/2C33H21N5.2C32H21N5.C27H17N5/c1-2-10-22(11-3-1)30-25-12-4-6-14-27(25)34-32(36-30)23-17-19-24(20-18-23)38-28-15-7-5-13-26(28)31-33(38)37-21-9-8-16-29(37)35-31;1-2-10-22(11-3-1)23-17-19-24(20-18-23)30-25-12-4-6-14-27(25)34-33(36-30)38-28-15-7-5-13-26(28)31-32(38)37-21-9-8-16-29(37)35-31;1-2-12-22(13-3-1)36-28-19-9-6-16-25(28)33-31(36)24-15-5-8-18-27(24)37-26-17-7-4-14-23(26)30-32(37)35-21-11-10-20-29(35)34-30;1-2-12-22(13-3-1)31-33-24-15-5-7-17-26(24)36(31)27-18-8-9-19-28(27)37-25-16-6-4-14-23(25)30-32(37)35-21-11-10-20-29(35)34-30;1-2-10-18(11-3-1)24-19-12-4-6-14-21(19)28-27(30-24)32-22-15-7-5-13-20(22)25-26(32)31-17-9-8-16-23(31)29-25/h2*1-21H;2*1-21H;1-17H.
What are the key properties of 16-[2-(1-phenylbenzimidazol-2-yl)phenyl]-2,8,16-triazatetracyclo[7.7.0.02,7.010,15]hexadeca-1(9),3,5,7,10,12,14-heptaene;16-[2-(2-phenylbenzimidazol-1-yl)phenyl]-2,8,16-triazatetracyclo[7.7.0.02,7.010,15]hexadeca-1(9),3,5,7,10,12,14-heptaene;16-[4-(4-phenylphenyl)quinazolin-2-yl]-2,8,16-triazatetracyclo[7.7.0.02,7.010,15]hexadeca-1(9),3,5,7,10,12,14-heptaene;16-[4-(4-phenylquinazolin-2-yl)phenyl]-2,8,16-triazatetracyclo[7.7.0.02,7.010,15]hexadeca-1(9),3,5,7,10,12,14-heptaene;16-(4-phenylquinazolin-2-yl)-2,8,16-triazatetracyclo[7.7.0.02,7.010,15]hexadeca-1(9),3,5,7,10,12,14-heptaene?
16-[2-(1-phenylbenzimidazol-2-yl)phenyl]-2,8,16-triazatetracyclo[7.7.0.02,7.010,15]hexadeca-1(9),3,5,7,10,12,14-heptaene;16-[2-(2-phenylbenzimidazol-1-yl)phenyl]-2,8,16-triazatetracyclo[7.7.0.02,7.010,15]hexadeca-1(9),3,5,7,10,12,14-heptaene;16-[4-(4-phenylphenyl)quinazolin-2-yl]-2,8,16-triazatetracyclo[7.7.0.02,7.010,15]hexadeca-1(9),3,5,7,10,12,14-heptaene;16-[4-(4-phenylquinazolin-2-yl)phenyl]-2,8,16-triazatetracyclo[7.7.0.02,7.010,15]hexadeca-1(9),3,5,7,10,12,14-heptaene;16-(4-phenylquinazolin-2-yl)-2,8,16-triazatetracyclo[7.7.0.02,7.010,15]hexadeca-1(9),3,5,7,10,12,14-heptaene has a molecular weight of 2337.71 g/mol, XLogP of 36.33, 14 rotatable bonds, 0 hydrogen bond donors, and 25 hydrogen bond acceptors.
Where does this data come from?
All data for 16-[2-(1-phenylbenzimidazol-2-yl)phenyl]-2,8,16-triazatetracyclo[7.7.0.02,7.010,15]hexadeca-1(9),3,5,7,10,12,14-heptaene;16-[2-(2-phenylbenzimidazol-1-yl)phenyl]-2,8,16-triazatetracyclo[7.7.0.02,7.010,15]hexadeca-1(9),3,5,7,10,12,14-heptaene;16-[4-(4-phenylphenyl)quinazolin-2-yl]-2,8,16-triazatetracyclo[7.7.0.02,7.010,15]hexadeca-1(9),3,5,7,10,12,14-heptaene;16-[4-(4-phenylquinazolin-2-yl)phenyl]-2,8,16-triazatetracyclo[7.7.0.02,7.010,15]hexadeca-1(9),3,5,7,10,12,14-heptaene;16-(4-phenylquinazolin-2-yl)-2,8,16-triazatetracyclo[7.7.0.02,7.010,15]hexadeca-1(9),3,5,7,10,12,14-heptaene is sourced from PubChem (CID 158475803), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).